[Interpretation of "Guidelines for the Diagnosis and Treatment of Novel Coronavirus (2019-nCoV) Infection by the National Health Commission (Trial Version 5)"]
- PMID: 32033513
- DOI: 10.3760/cma.j.issn.0376-2491.2020.0001
[Interpretation of "Guidelines for the Diagnosis and Treatment of Novel Coronavirus (2019-nCoV) Infection by the National Health Commission (Trial Version 5)"]
Abstract
the National Health Commission of the People's Republic of China publish the guidelines for the diagnosis and treatment of novel coronavirus (2019-nCoV) infection (trial version 5) .With the awareness and understanding of the disease, the guidelines have been revised for recognize, treat, and prevent diseases. Then, what are the contents of the fifth edition of the guide issued updated compared to the fourth edition, now, learn together.
国家卫生健康委员会(以下简称卫健委)发布了《新型冠状病毒感染的肺炎诊疗方案(试行第五版)》,随着对疾病不断地认识和了解,诊疗方案也随之进行修订。诊疗方案(以下简称方案)的发布指导我们认识疾病、治疗疾病、预防疾病。那么,卫健委发布的第五版诊疗方案较第四版具体更新了哪些内容,本文进行了解读。.
Keywords: 2019 Novel coronavirus; guidelines; pneumonia.
Comment in
-
Association between age and clinical characteristics and outcomes of COVID-19.Eur Respir J. 2020 May 27;55(5):2001112. doi: 10.1183/13993003.01112-2020. Print 2020 May. Eur Respir J. 2020. PMID: 32312864 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources